Rituximab use in children with complicated idiopathic nephrotic syndrome - a single centre experience

Autor: Moreira,Carla Leal, Baptista,Rita, Sousa,Pedro Maneira, Maciel,Juliana, Costa,Liane, Teixeira,Ana, Costa,Teresa, Matos,Paula, Rocha,Liliana, Faria,Maria Sameiro, Mota,Conceição

Publikováno v: NASCER E CRESCER-BIRTH AND GROWTH MEDICAL JOURNAL; Vol 28 No 2 (2019); 70-76
NASCER E CRESCER-BIRTH AND GROWTH MEDICAL JOURNAL; vol. 28 n.º 2 (2019); 70-76
NASCER E CRESCER-BIRTH AND GROWTH MEDICAL JOURNAL; Vol. 28 No. 2 (2019); 70-76
NASCER E CRESCER-BIRTH AND GROWTH MEDICAL JOURNAL; Vol. 28 N.º 2 (2019); 70-76
Repositório Científico de Acesso Aberto de Portugal
Repositório Científico de Acesso Aberto de Portugal (RCAAP)
instacron:RCAAP
Nascer e Crescer, Vol 28, Iss 2, Pp 70-76 (2019)
Nascer e Crescer v.28 n.2 2019
Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Agência para a Sociedade do Conhecimento (UMIC)-FCT-Sociedade da Informação

Background: In children with idiopathic nephrotic syndrome, rituximab can maintain short-term remission allowing steroids and calcineurin inhibitors taper. Methods: We retrospectively reviewed all children receiving rituximab for idiopathic nephrotic

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88c2f3e29c9109a4c21703a26b643b76
https://revistas.rcaap.pt/nascercrescer/article/view/15974